Eprozinol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Eprozinol
Eprozinol.png
Names
IUPAC name
(RS)-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-1-ol
Identifiers
  • 32665-36-4 ☑Y
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL2107691 ☒N
ChemSpider
  • 109268 ☒N
ECHA InfoCard 100.046.482
KEGG
  • D07379 ☑Y
PubChem CID
  • 122553
UNII
  • IJ21AK8IVJ ☑Y
Properties
C22H30N2O2
Molar mass 354.4858
Pharmacology
R03DX02 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Eprozinol is a drug for obstructive airway disease.[1][2]

References

  1. ^ Nicrosini, F.; Carpinella, G. (1978). "Eprozinol treatment of chronic bronchitis with dyspnea and cough". Broncho-pneumologie. 28 (4): 322–327. PMID 756799.
  2. ^ Labrid, C.; Duchene-Marullaz, P.; Rispat, G. (1981). "Mechanisms of anti-bronchoconstrictive effects of eprozinol. II. In vivo studies on the guinea pig". Pharmacology. 23 (1): 48–55. doi:10.1159/000137526. PMID 7312935.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Eprozinol&oldid=769299159"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Eprozinol
This page is based on the copyrighted Wikipedia article "Eprozinol"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA